3rd Annual MarketsandMarkets

Single-Cell Analysis Conference

23rd -24th June 2022

Hyatt Regency Boston/Cambridge

Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.

Our 3rd Annual MarketsandMarkets Single-Cell Analysis Conference scheduled to be held on 23rd and 24th June 2022 in Hyatt Regency Boston/Cambridge  aims to bring together the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe to address the recent developments and challenges in analyzing single cell and also provides the platform to share the knowledge with academic peers and present their research papers and reports.

 

CO-LOCATED CONFERENCES

5th Annual MarketsAndMarkets Next-Gen Immuno-Oncology Conference

WHAT TO EXPECT

  • Integrating Bulk- Single Cell and Spatial Transcriptomics towards integrative disease understanding
  • ScRNA-Seq Data for Single-Cell Analysis
  • Multi-Omics of Single Cells: Strategies and Applications
  • Single-Cell Genome-Wide Bisulfite Sequencing
  • Single-Cell Analysis in Cancer Genomics
  • Nanopore Technology – A Potential Application in Functional Genomics  
  • Algorithmic advances in Machine Learning & Artificial Intelligence for single cell expression analysis
  • Current Methodologies and Challenges of Single-Cell and Single-Nucleus RNA-Sequencing

  • Learn about the Single- Cell Biology and its applications
  • Meet global leaders and researchers from the industry and Academics
  • 100+ Professional attending from all around the globe
  • Access to online presentations on-demand post-summit
  • Case studies presented from leading technology collaborations 
  • Interactive panel discussions
  • Futuristic Agenda
  • Program address the recent challenges in the field of research

Professionals in Healthcare, Therapeutics, Universities/Pharmaceuticals:

  • C-Level
  • Vice Presidents
  • Presidents
  • Senior Directors
  • Directors
  • Global Heads
  • Heads
  • Managers
  • Postdocs
  • Senior Scientists
  • Senior Researchers
  • Professors
  • Bioinformatician
  • Computational Biologist

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairman

08:55 - 09:00

Overview of Developments in Single-Cell Technology

Keynote Presentation - The evolving role of Integrating Bulk- Single Cell and Spatial Transcriptomics towards integrative disease understanding

Arvind Rao

Arvind Rao, Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor

09:00 - 09:30

Leveraging single cell technologies to uncover key regulators of (multi)cellular processes: Applications to tumor immunology

Livnat Jerby

Livnat Jerby, Assistant Professor of Genetics, Stanford University

09:30 - 10:00

Meet 10X single cell RNA sequencing from Novogene

Eric Iverson

Eric Iverson, Technical Support Supervisor, Novogene Corporation Inc.

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Distinguishing cancer cells from normal cells in single-cell RNA sequencing data sets

Alexandre Alloy

Alexandre Alloy, Scientist - Computational Biology, Bristol Myers Squibb

11:15 - 11:45

Detect of the undetectable unconventional circulating neoplastic cells: Pancreatic Ductal Adenocarcinoma detection from liquid biopsy samples

Yu-Jui Chiu

Yu-Jui Chiu, Associate Scientist, CEDAR, OHSU Knight Cancer Institute, School of Medicine

11:45 - 12:15

Sequencing Technologies and its Applications in Single-Cell Analysis

Recent advances in spatial and single-cell proteome profiling

Yiran Liang

Yiran Liang, Research Associate, Dr. Ryan Kelly’s lab - Department of Chemistry and Biochemistry - Brigham Young University

12:15 - 12:45

Combining sequence and structure information from DNA (genomics), RNA (Coding and Noncoding), and proteins, to better understand genome organization and function

Miten Jain

Miten Jain, Assistant Research Scientist, University of California Santa Cruz

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Evaluating Neoantigen Immunotherapies in the Clinic

Matt Davis

Matt Davis, Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

14:15 - 14:45

Protein Quantification from a Single Cell Using TMTpro™ Mass Spectrometry

Jessica McDonough

Jessica McDonough, Co-Founder, Attivare Therapeutics

14:45 - 15:15

Single Cell Analysis for Cell-Based Therapies

Anka G. Ehrhardt

Anka G. Ehrhardt, Director, Cell-Based Sciences, AR&D, Merck

15:15 - 15:45

Diving into Multi-Omics Single-Cell Analysis

Bulk and scRNA-seq analysis of the developing vertebrate retina reveals complex epigenetic regulation of the CTBP2/RIBEYE locus.

Ray Enke

Ray Enke, Associate Professor of Biology, James Madison University

16:30 - 17:00

Prioritizing the Next-Gen Technologies in the Universe of Single-Cell Analysis

Breakout Session: State-of-the art and future of Single-cell technologies

Ajay Nair

Ajay Nair, Associate Research Scientist, Columbia University in the City of New York

17:00 - 17:30

End of Day 1 followed by Drinks Reception and Networking

17:35 - 17:35

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Tailoring Models and Therapies under Single Cell Analysis

Opening Remarks from the Chairman

08:55 - 09:00

Keynote Presentation- Identifying Master Regulators Causing Diseases Using Single-Cell Analysis

Ajay Nair

Ajay Nair, Associate Research Scientist, Columbia University in the City of New York

09:00 - 09:30

Single Cell Mass Cytometry and AI-Guided Analysis to Predict Therapeutic Response and Monitor and Direct Clinical Trials

09:30 - 10:00

Elucidating the cellular states of CD8+ T cells regulating anti-PD1 response using multi-omics single cell sequencing

Namit Kumar

Namit Kumar, Principal Scientist - Early Development Predictive Sciences, Bristol Myers Squibb

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:00

Single-Cell Functional Proteomics by Cyclic MIST Chip for Human Disease Study

Jun Wang

Jun Wang, Associate Professor, Stony Brook University

11:15 - 11:45

Single Cell Gene Regulatory Network Perturbations in Disease

S. Stephen Yi

S. Stephen Yi, University of Texas at Austin, Director of Bioinformatics, Faculty of Biomedical Engineering and Oncology

11:45 - 12:15

Breakout Session by- Why Single-Cell Analysis and How?

Namit Kumar

Namit Kumar, Principal Scientist - Early Development Predictive Sciences, Bristol Myers Squibb

12:15 - 12:45

Shaping the Single-Cell Medicine Era with Multi-Model Analysis

Multiplexed Image Platforms for Cancer Immunoprofiling and Biomarker Discovery

Edwin Roger Parra Cuentas

Edwin Roger Parra Cuentas, Director of the Multiplex Immunoflouresence and Image Analysis Laboratory, The University of Texas MD Anderson Cancer

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

End of Conference

14:15 - 14:15

Closing Remarks from the Chairman

15:45 - 15:50

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meeting

15:50 - 16:50

CONFERENCE SPEAKERS

ADVISORS

Yuhwa Lo

Yuhwa Lo

Professor, Electrical & Computer Engineering, University of California, San Diego

Arvind Rao

Arvind Rao

Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor

Alexandre Alloy

Alexandre Alloy

Scientist - Computational Biology, Bristol Myers Squibb

Joshua Campbell

Joshua Campbell

Professor, Boston University School of Medicine

SPEAKERS

Edwin Roger Parra Cuentas

Edwin Roger Parra Cuentas

Director of the Multiplex Immunoflouresence and Image Analysis Laboratory, The University of Texas MD Anderson Cancer

Yiran Liang

Yiran Liang

Research Associate, Dr. Ryan Kelly’s lab - Department of Chemistry and Biochemistry - Brigham Young University

S. Stephen Yi

S. Stephen Yi

University of Texas at Austin, Director of Bioinformatics, Faculty of Biomedical Engineering and Oncology

Jessica McDonough

Jessica McDonough

Co-Founder, Attivare Therapeutics

Yu-Jui Chiu

Yu-Jui Chiu

Associate Scientist, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Miten Jain

Miten Jain

Assistant Research Scientist, University of California Santa Cruz

Eric Iverson

Eric Iverson

Technical Support Supervisor, Novogene Corporation Inc.

Namit Kumar

Namit Kumar

Principal Scientist - Early Development Predictive Sciences, Bristol Myers Squibb

Alexandre Alloy

Alexandre Alloy

Scientist - Computational Biology, Bristol Myers Squibb

Yuhwa Lo

Yuhwa Lo

Professor, Electrical & Computer Engineering, University of California, San Diego

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

Jun Wang

Jun Wang

Associate Professor, Stony Brook University

Anka G. Ehrhardt

Anka G. Ehrhardt

Director, Cell-Based Sciences, AR&D, Merck

Ray Enke

Ray Enke

Associate Professor of Biology, James Madison University

Livnat Jerby

Livnat Jerby

Assistant Professor of Genetics, Stanford University

Ajay Nair

Ajay Nair

Associate Research Scientist, Columbia University in the City of New York

Arvind Rao

Arvind Rao

Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Hyatt Regency Boston/Cambridge

PAST EVENT GALLERY